Endothelial Injury and Repair as a Working Paradigm

Size: px
Start display at page:

Download "Endothelial Injury and Repair as a Working Paradigm"

Transcription

1 Endothelial Injury and Repair as a Working Paradigm A. Linke ESC Meeting 2010 UNIVERSITÄTLEIPZIG H ERZZEN TRUM

2 Physiology of Endothelial Function: Regulation of Vascular Tone L-Arg. L-Arg. Agonists Shear Stress Vascular Lumen Gefäßlumen L-Arg. L-Arg. + enos + Citrullin L-Citrulline Endothelial Endothelzelle Cell L-Arg. NO Extrazellularraum Extracellular Space NO GTP cgmp Ca 2+ Glatte Gefäßmuskelzelle Vascular Smooths Muscle Peroxynitrite

3 Pathophysiology Endothelial Dysfunction The conditio sine qua non for atherogenesis J. Ross, Nature 1993;362:

4 Pathophysiology of Endothelial Dysfunction in Cardiovascular Disease L-Arg. L-Arg. Vascular Lumen Gefäßlumen L-Arg. L-Arg. enos enos Citrullin L-Citrulline Endothelial Endothelzelle Cell L-Arg. NO ROS Extrazellularraum Extracellular Space NO GTP cgmp Ca 2+ Glatte Gefäßmuskelzelle Vascular Smooths Muscle Peroxynitrite

5 Therapeutic options in CAD: Exercise Training

6 Assessment of Endothelial Function Infusion Catheter Doppler Guide Wire, 12 MHz Coronary Artery ( target vessel ) 1 cm Distal Diameter

7 Shear Stress, Physical Activity and Endothelial Function Inclusion Criteria Coronary 1/2 Vessel Disease Preserved LV Function Stenosis Requiring Intervention Endothelial Dysfunction in Another Coronary Artery = Target Vessel Study Design Stable CAD (19 Pat.) Assessment of Endothelial Function Ergometer-Training 6x/d for 4 Weeks Control 4 Wo. Acetylcholine Assessment of Endothelial Function Hambrecht R, N Engl J Med 2000(342):454-60

8 Shear Stress, Physical Activity and Endothelial Function Training Group Control Group D Coronary Blood FLow [%] Begin 4 Weeks Begin 4 Weeks p<0.05 vs.kontrolle Hambrecht R, N Engl J Med 2000(342):454-60

9 Molecular Mechanisms: Exercise Training

10 Activation of enos by shear stress Shear stress Vessel PDK PI3K Akt P P S 1177 HSP90 Endothelium P enos P

11 LIMA-Study: Design Patients with stable CAD and indication for CABG (n=35) In-vivo-Assessment of Endothelial Function (LIMA) Control (n=18) Usual care 4 weeks Training (n=17) Daily Raw- / Bicycle ergometer training (4-6/d), 4 weeks In-vivo-Assessment of Endothelial Function (LIMA) In-vitro-Assessment of Endothelial Function (LIMA-Ring), Molecular Analysis of RNA- and Protein Expression Hambrecht R. et al., Circulation 2003

12 D APV vs. Baseline [%] Relaxation [%] Impact of exercise training on average peak blood flow velocity (APV) and Vasorelaxation of the LIMA ACH-induced APV after 4 weeks: - in vivo - Acetylcholine-induced Relaxation - in vitro p < 0.05 vs. Control Training Control p< Control Training Acetylcholine [µmol/l] Acetylcholine [µmol/l] Hambrecht R. et al., Circulation 2003

13 enos-expression [rel. Units] Protein expression [rel. units] Impact of Exercise Training on enos-expression and -Phosphorylation enos-expression C T C T enos-phosphorylation (Ser1177) K K T T 1.5 p< p< Control Training 0.0 Control Training Circulation 2003 (107):3452

14 D APV [rel. Units] Association between enos Ser1177 and DAPV 20 r=0.59 p< 0.02 Exercise Training Group p-enos Ser1177 [rel. Units] Hambrecht et al., Circulation 2003

15 NAD(P)H Oxidase - Subunits O 2 - O2 Rac Rap1A p47 gp91 p67 p22 Aktivation Phosphorylation NADPH NADP + Rap1A Rac gp91 p47 P p22 p67 Different Isoforms of gp91 phox described: Nox1 to Nox5, Nox2 = gp91 phox (Cheng et al., Gene 2001) In vessels: Nox-1, Nox-2 und Nox-4 mit relevanter Aktivität In endothelial cells: Nox-2 In vascular smooth muscle cells: Nox-1 und Nox-4

16 Gp91 phox / 18S-rRNA [x100] Nox4 / 18S-rRNA [x100] p22 phox / 18S-rRNA [x100] Expression of NAD(P)H Oxidase Subunits gp91 phox Nox4 p22 phox Control Training 0.0 Control Training 0 Control Training Adams V et al., Circulation 2005

17 NAD(P)H Oxidase-Activity and ROS-Production: Impact of Exercise Training NAD(P)H-Oxidase-Aktivity ROS-Generation NAD(P)H-Oxidase-Activity [mu/mg] Control p<0.05 Training ROS-Generation [DOD 550 / min] Control p<0.05 Training Adams V et al., Circulation 2005

18 Correction of Endothelial Dysfunktion by Exercise Training Endotheliale Dysfunktion O 2 - NO Exercise Training O 2 - NO enos Expression p-ecnos and p-akt NAD(P)H subunits p22 phox and gp91 phox Ang II-Receptor 1 Prognostic Implication?

19 Molecular Mechanisms: Importance of endogenous progenitor and stem cells

20 Function of EPCs Bone marrow Proliferation EPC Blood vessel Endothelium Recruitment Differentiation Mobilization Target organ Vasculogenesis in-situ EPC differentiation and proliferation

21 Application of ex vivo cultivated EPCs - Results from animal models - human human Medium mature EC EPCs Immediately after ischemia MNCs 7 days in culture 28 days after EPC application Animal model of Hind limb ischemia Kalka C et al., PNAS 2000; 97:3422

22 Progenitor Cells Regenerate Damaged Endothelium - Results from animal experiments - Friedrich E et al., Circ Res 2006; 98:e20

23 Apoptotic index Apopt. Endothelial Cells [%] Endothelial Integrity: Turnover of Endothelial Cells Oxidant stress oxldl Rössig L, J Am Coll Cardiol 2000(36):2081 Di-LDL/FITC-Lectin positive Cells Angiotensine II Catecholamine Cytokines Endotoxin Growth factor deficiency Control CHF Bone marrow Proapoptotic factors Endothelial progenitor cells Apoptosis

24 Molecular Mechanisms: Impact of ischemia on EPC release

25 Impact of an acute bout of exercise on EPC release Myocardial Ischemia (I) Pts with CAD and exercise induced ischema Control (C) Pts with CAD having no evidence of exercise-induced ischemia Healthy Subjects (HS) maximal symptom-limited bicycle ergometry Blood samples at 2, 4, 6, 8, 24, 48, 72, 96, 120 and 144h after the exercise test FACS-Analysis: Detection of CD34+/KDR+ cells in the blood Cell culture: Measurement of Di-acLDL/FITC-lectin positive cells after 4 days in culture Adams et al., Arterioscler Thromb Vasc Biol 2004

26 x-fold increase in CD34 + /KDR + cells vs. begin Impact of an acute bout of exercise on EPC mobilization 4 $ # Healthy subjects (HS) CAD without Ischemia (C) 3 2 $ # CAD with ischemia (I) $: p<0.05 vs. Beginn; #: p<0.05 vs. C and HS Time after exercise [h] Adams et al., Arterioscler Thromb Vasc Biol 2004

27 EPC-Mobilisation by Exercise Training: Results of 2 randomized studies Patients with PAOD Fontaine II b (n=18) Maximal Exercise Test on the Treadmill Blood sampling Patients CAD with patients PAOD after PTA (n=31) (n=18) Maximal max. exercise Exercise test Test on a on treadmill the Treadmill blood Blood samples sampling Ischemic Training (n=9) Inactive Control (n=9) Non-ischemic ET ET below at the AP-Threshold 75% of peak HR (n=15) (n=9) Inactive Inactive control Control (n=16) (n=9) Blood sampling (every week) blood Blood samples sampling (every (weekly) week) Maximal Exercise Test after 4 weeks Sandri M, et al; Circulation 2005

28 EPC Mobilization by Exercise Training Begin Circulating CD34 + /KDR + Cells Begin acldl + /Lectin + Zellen After 4 weeks After 4 weeks Sandri M, et al; Circulation 2005

29 x-facher x-fold increase Anstieg in CD34 CD34 + /KDR + /KDR + Zellen + cells vs. Beginn x-fold increase in CD34 + /KDR + cells vs. Begin EPC Mobilization by Exercise Training Ischemic Training Non-ischemic Training p<0.05 vs. Kontrolle Control Training Training PAOD-Patients CAD after patients PTA Kontrolle Control Training Control Control Training Time Zeit [d] [d] Time time [d] Sandri M, et al; Circulation 2005

30 Impact of Exercise Training on the Expression of Homing Factors Non-ischemia Training (n=9) Ischemic Training (n=9) mrna-expression [arb. units] mrna-expression [arb. units] CXCR4 and CPC-Homing in ischemic tissues Migration following An SDF1- Gradient CPC CXCR4 SDF-1 Ischemia CXCR4-Expression in patients with PAOD Begin 4 Wo Begin 4 Wo Training Control Begin 4 Wo Begin 4 Wo Training Control Sandri M, et al; Circulation 2005 p<0.05 vs. Begin and Control

31 Nicht-ischäm. Training % integrated CPCs Ischäm. Training % integrated CPCs Impact of Exercise Training on EPC function Matrigel-Assay Patients with PAOD Begin 4 Wo Begin 4 Wo Training (n=9) Control (n=9) blue = nucleus red = endothelial cells green = EPCs Beginn 4 Wo Begin 4 Wo Training (n=9) Control (n=9) Sandri M, et al; Circulation 2005 p<0.05 vs. Control

32 Impact of Exercise Training on the Mobilization of EPCs Improvement of myocardial Perfusion Endothelial Regeneration?? Arterio-/ Vasculogenesis Ischemia (HIF1a ) PI3K pakt NO circulating EPCs VEGF

33

34 Thank you!

How does Exercise Work at the Cellular/Molecular Level

How does Exercise Work at the Cellular/Molecular Level How does Exercise Work at the Cellular/Molecular Level Volker Adams, PhD ESC, Paris 28. Aug. 211 UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Nothing to disclose Survival Exercise Training in Patients With

More information

PCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure

PCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure

More information

ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH

ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH ENDOTHELIAL PROGENITOR CELLS AS A NOVEL BIOMARKER OF VASCULAR HEALTH I Jialal, MD, PhD. FRCPath.DABCC Robert E. Stowell Chair in Experimental Pathology Professor of Pathology and Medicine Director, Laboratory

More information

Microvascular Disease: How to Diagnose and What s its Treatment

Microvascular Disease: How to Diagnose and What s its Treatment Microvascular Disease: How to Diagnose and What s its Treatment Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of

More information

115 Endothelial Progenitor Cells: A Novel Laboratory-Based Biomarker of Vascular Health. Ishwarlal Jialal

115 Endothelial Progenitor Cells: A Novel Laboratory-Based Biomarker of Vascular Health. Ishwarlal Jialal 115 Endothelial Progenitor Cells: A Novel Laboratory-Based Biomarker of Vascular Health Ishwarlal Jialal 211 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 16 Chicago,

More information

Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart

Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart Involvement of the microrna-150-cxcr4-sdf-1α pathway Emeline Goretti, MSc No conflict of interest Endothelial

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST F. Baborski 1, I. Scuric 1, D. Cerovec 1, M. Novoselec 1, V. Slivnjak 1, K. Fuckar 1, N. Lakusic 1, Z. Vajdic 2, R. Bernat 3, K. Kapov-Svilicic 3 (1) Special Hospital

More information

The Study of Endothelial Function in CKD and ESRD

The Study of Endothelial Function in CKD and ESRD The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:

More information

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest DECLARATION OF CONFLICT OF INTEREST No conflicts of interest University Heart Centre Tübingen Angiogenic actions of platelets Meinrad Gawaz, MD, FESC Tübingen, Germany ESC 2011 Paris GPIb GPIb GPVI TxA2

More information

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results Department of Cardiovascular Medicine Università Cattolica del Sacro Cuore Rome, Italy Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress

More information

Endothelial PGC 1 - α 1 mediates vascular dysfunction in diabetes

Endothelial PGC 1 - α 1 mediates vascular dysfunction in diabetes Endothelial PGC-1α mediates vascular dysfunction in diabetes Reporter: Yaqi Zhou Date: 04/14/2014 Outline I. Introduction II. Research route & Results III. Summary Diabetes the Epidemic of the 21st Century

More information

Myocardial infarction

Myocardial infarction NEW CARDIAC MARKERS AND CARDIAC REGENERATION Päivi Lakkisto, MD, PhD Specialist in Clinical Chemistry Clinical lecturer University of Helsinki and HUSLAB Minerva Institute for Medical Research Myocardial

More information

Intolerance in Heart Failure

Intolerance in Heart Failure Novel Targets to Attack Exercise Intolerance in Heart Failure - Skeletal Muscle - Volker Adams, PhD ESC, Paris 3. Aug. 211 UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Nothing to disclose Myers et al. NEJM

More information

Statins and endothelium function

Statins and endothelium function Statins and endothelium function Matthias Endres Berlin, Germany Klinik und Poliklinik für Neurologie Conflict of interest: research grant from AstraZeneca from prevention to acute therapy... Pleiotropic

More information

Role of Inflammation in Pulmonary Hypertension

Role of Inflammation in Pulmonary Hypertension Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial

More information

Enhancing Treatment for Cardiovascular Disease: Exercise and Circulating Angiogenic Cells

Enhancing Treatment for Cardiovascular Disease: Exercise and Circulating Angiogenic Cells ARTICLE Enhancing Treatment for Cardiovascular Disease: Exercise and Circulating Angiogenic Cells Sarah Witkowski 1, Nathan T. Jenkins 2, and James M. Hagberg 2 1 The University of Massachusetts, Department

More information

Reprogramming through micrornas Stefanie Dimmeler

Reprogramming through micrornas Stefanie Dimmeler Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main Reprogramming through micrornas Stefanie Dimmeler Conflict of interest: T2cure GmbH, Miragen Non-coding DNA & RNA and micrornas Human Genome

More information

Assessment of Ischemia and Viability

Assessment of Ischemia and Viability EAE Teaching Course Bucharest, 2010 Assessment of Ischemia and Viability Jens-Uwe Voigt Dpt. of Cardiology University Leuven Belgium Assessment of Ischemia & Viability resting wall motion Stress Testing

More information

Ischemia and Reperfusion: Pharmacological treatment options

Ischemia and Reperfusion: Pharmacological treatment options Physiologisches Institut Ischemia and Reperfusion: Pharmacological treatment options Prof. Dr. Rainer Schulz Plaque rupture and myocardial ischemia Acute plaque rupture (Stary VI) Ischemic myocardium (ACS,

More information

Effets Vasculaires des Flavonoïdes Alimentaires et leurs Mécanismes

Effets Vasculaires des Flavonoïdes Alimentaires et leurs Mécanismes Académie Nationale de Pharmacie Mercredi 27 janvier 21 Faculté de Pharmacie de Paris Effets Vasculaires des Flavonoïdes Alimentaires et leurs Mécanismes V.B. Schini-Kerth CNRS UMR 7213 Équipe Pharmacologie

More information

Cancer therapy, cardiovascular toxicity and hypertension

Cancer therapy, cardiovascular toxicity and hypertension Cancer therapy, cardiovascular toxicity and hypertension Rhian M Touyz MBBCh, PhD Disclosures: None Capri Cardiovascular Conference 2.0, Capri 15-16 April 2016 Vascular phenotype in hypertension Normotensive

More information

Control of Myocardial Blood Flow

Control of Myocardial Blood Flow Control of Myocardial Blood Flow Blood goes where it is needed John Hunter, 1794 Cited by Dunker DJ and Bache RJ Physiol Rev, 2008 Bernard De Bruyne, MD, PhD Cardiovascular Center Aalst OLV-Clinic Aalst,

More information

Cardiovascular Protection and the RAS

Cardiovascular Protection and the RAS Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular

More information

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine

More information

PhD THESIS Epigenetic mechanisms involved in stem cell differentiation

PhD THESIS Epigenetic mechanisms involved in stem cell differentiation Romanian Academy Institute of Cellular Biology and Pathology "Nicolae Simionescu" PhD THESIS Epigenetic mechanisms involved in stem cell differentiation Coordinator: Acad. Maya Simionescu PhD Student:

More information

Conflict of Interest Slide

Conflict of Interest Slide Comparison of six- month clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation (EECP) for coronary artery disease in the United States and Europe Ozlem

More information

World Journal of Cardiology. Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects

World Journal of Cardiology. Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects W J C World Journal of Cardiology Online Submissions: http://www.wjgnet.com/esps/ wjc@wjgnet.com doi:10.4330/wjc.v4.i12.312 World J Cardiol 2012 December 26; 4(12): 312-326 ISSN 1949-8462 (online) 2012

More information

Myocardial Perfusion: Positron Emission Tomography

Myocardial Perfusion: Positron Emission Tomography Myocardial Perfusion: Positron Emission Tomography TH. Schindler, MD University Hospitals of Geneva, Cardiovascular Center, Geneva, Switzerland ESC 2010 Stockholm Personal Disclosure Research Grant support

More information

Professor Harvey White. Interventional Cardiologist Auckland

Professor Harvey White. Interventional Cardiologist Auckland Professor Harvey White Interventional Cardiologist Auckland Stem cells and the heart Harvey White Director of Coronary Care Unit and Cardiovascular Research Unit Green Lane Cardiovascular Service Auckland

More information

Pathophysiology of Coronary Microvascular Dysfunction

Pathophysiology of Coronary Microvascular Dysfunction Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive

More information

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010 ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010 CORONARY ARTERY DISEASE AND NUCLEAR IMAGING: AN UPDATE PERFUSION SCINTIGRAPHY IN HIGH-RISK ASYMPTOMATIC PATIENTS Pasquale Perrone Filardi Federico

More information

In stable ischemic vascular syndromes, exercise has been. Exercise Physiology

In stable ischemic vascular syndromes, exercise has been. Exercise Physiology Exercise Physiology Effects of Exercise and Ischemia on Mobilization and Functional Activation of Blood-Derived Progenitor Cells in Patients With Ischemic Syndromes Results of 3 Randomized Studies Marcus

More information

WHY ADMINISTER CARDIOTONIC AGENTS?

WHY ADMINISTER CARDIOTONIC AGENTS? Cardiac Pharmacology: Ideas For Advancing Your Clinical Practice The image cannot be displayed. Your computer may not have enough memory to open the image, or Roberta L. Hines, M.D. Nicholas M. Greene

More information

63 yo woman with chest pain

63 yo woman with chest pain 63 yo woman with chest pain Coronary Microvascular Disease: Does It Exist? EA Amsterdam, MD Distinguished Professor Cardiology and Internal Medicine UC Davis School of Medicine and Medical Center Sacramento,

More information

Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment

Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment 2016 춘계심혈관통합학술대회, 경주 Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment Youngkeun Ahn, MD, PhD Department of Cardiology, Cardiovascular Center Chonnam National University

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O.

CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O. CURRENT STATUS OF STRESS TESTING JOHN HAMATY D.O. INTRODUCTION Form of imprisonment in 1818 Edward Smith s observations TECHNIQUE Heart rate Blood pressure ECG parameters Physical appearance INDICATIONS

More information

The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research

The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex

More information

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all

More information

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine

More information

Cardiovascular Imaging Stress Echo

Cardiovascular Imaging Stress Echo Cardiovascular Imaging Stress Echo Theodora A Zaglavara, MD, PhD Cardiac Imaging Department INTERBALKAN MEDICAL CENTER Thessaloniki GREECE Evolution of Stress Echo: From Innovation to a Widely Established

More information

Exercise Intolerance in Heart Failure: Significance of Skeletal Muscle Abnormalities

Exercise Intolerance in Heart Failure: Significance of Skeletal Muscle Abnormalities Exercise Intolerance in Heart Failure: Significance of Skeletal Muscle Abnormalities Hokkaido University Graduate School of Medicine Shintaro Kinugawa Survival rate (%) Peak oxygen uptake and prognosis

More information

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular

More information

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Dyslipidemia Endothelial dysfunction Free radicals Immunologic ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and

More information

Inflammatory Markers and Anti- Inflammatory Effects of Insulin

Inflammatory Markers and Anti- Inflammatory Effects of Insulin Inflammatory Markers and Anti- Inflammatory Effects of Insulin Paresh Dandona, BSc, MD, DPhil, FRCP, FACP, FACC, FACE Distinguished Professor of Medicine and Pharmacology School of Medicine and Biomedical

More information

Nox-Dependent Mechanisms of Cardiomyocyte Dysfunction in a Model of Pressure Overload

Nox-Dependent Mechanisms of Cardiomyocyte Dysfunction in a Model of Pressure Overload Nox-Dependent Mechanisms of Cardiomyocyte Dysfunction in a Model of Pressure Overload Giovanna Frazziano, PhD Vascular Medicine Institute Department of Pharmacology and Chemical Biology University of Pittsburgh

More information

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital

How to Evaluate Microvascular Function and Angina. Myeong-Ho Yoon Ajou University Hospital How to Evaluate Microvascular Function and Angina Myeong-Ho Yoon Ajou University Hospital Angina without Coronary Artery Disease (CAD) Prevalence: 20-30% going c-angiography, with a higher prevalence (almost

More information

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension

In the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial

More information

Maria Angela S. Cruz-Anacleto, MD

Maria Angela S. Cruz-Anacleto, MD Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort

More information

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009

Cardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics

More information

Women and Coronary Artery Disease:

Women and Coronary Artery Disease: Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist

More information

Cell Therapy Update what have we learned from clinical trials?

Cell Therapy Update what have we learned from clinical trials? Andreas M. Zeiher, MD Dept. of Internal Medicine III University of Frankfurt Germany Cell Therapy Update what have we learned from clinical trials? Cardiology Update 2011, Davos, 2 / 2011 Disclosure information:

More information

Update on stem cells in cardiovascular disease

Update on stem cells in cardiovascular disease Andreas M. Zeiher, MD Dept. of Internal Medicine III University of Frankfurt Germany Update on stem cells in cardiovascular disease Cardiology Forum 2010, Rome, 05 / 2010 Disclosure information: Guidant

More information

ESC Congress August 2011 Paris France. VEGFs and the angiogenic paradox in diabetic patients

ESC Congress August 2011 Paris France. VEGFs and the angiogenic paradox in diabetic patients ESC Congress 2011 27. 31. August 2011 Paris France VEGFs and the angiogenic paradox in diabetic patients Session: New features and effects of angiogenic growth factors in vascular diseases. Johannes Waltenberger,

More information

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis

More information

Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases

Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and

More information

Personalized Medicine: An

Personalized Medicine: An Comparative Effectiveness and Personalized Medicine: An Essential interface Clinical exemplers of personalized medicine i Clyde Yancy, MD, FACC, FAHA, MACP Medical Director, Baylor Heart and Vascular Institute

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI

Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Metabolic Syndrome Is A Key Determinant Of Coronary Microvascular Function In Patients With Stable Coronary Disease Undergoing PCI Narbeh Melikian*, Ajay M Shah*, Martyn R Thomas, Roy Sherwood, Mark T

More information

Diminished Circulating Monocytes after Peripheral Bypass Surgery for Critical Limb Ischemia

Diminished Circulating Monocytes after Peripheral Bypass Surgery for Critical Limb Ischemia Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 5-6-2009 Diminished Circulating Monocytes after Peripheral Bypass

More information

BIOAUTOMATION, 2009, 13 (4), 89-96

BIOAUTOMATION, 2009, 13 (4), 89-96 Preliminary Results оf Assessment of Systolic and Diastolic Function in Patients with Cardiac Syndrome X Using SPECT CT Tsonev Sv. 1, Donova T. 1, Garcheva M. 1, Matveev M. 2 1 Medical University Sofia

More information

Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell

Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell Mini Forum for Cardiovascular Stem Cell Acta Cardiol Sin 2014;30:375 381 Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell Po-Hsun Huang, 1,3,5 Jaw-Wen Chen 1,2,4,5 and Shing-Jong Lin

More information

The dynamic regulation of blood vessel caliber

The dynamic regulation of blood vessel caliber INVITED BASIC SCIENCE REVIEW The dynamic regulation of blood vessel caliber Colleen M. Brophy, MD, Augusta, Ga BACKGROUND The flow of blood to organs is regulated by changes in the diameter of the blood

More information

Financial Disclosures. Bone Marrow Mononuclear Cells. Cell Based Therapies: What Do They Do and Will They Work in CLI?

Financial Disclosures. Bone Marrow Mononuclear Cells. Cell Based Therapies: What Do They Do and Will They Work in CLI? Cell Based Therapies: What Do They Do and Will They Work in CLI? None Financial Disclosures Michael P. Murphy, MD The Vascular and Cardiac Adult Stem Cell Therapy Center Indiana University School of Medicine

More information

Endothelial Dysfunction in Obesity. Justin D. La Favor. November, 2012

Endothelial Dysfunction in Obesity. Justin D. La Favor. November, 2012 NADPH Oxidase as a Mechanistic Link Between Erectile Dysfunction, Peripheral, and Coronary Endothelial Dysfunction in Obesity by Justin D. La Favor November, 2012 Director of Dissertation: Robert C. Hickner

More information

Steven S. Saliterman, MD, FACP

Steven S. Saliterman, MD, FACP Ashley Wagner, Sochi 2014 www.gotceleb.com Steven S. Saliterman, MD, FACP Adjunct Professor Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Aerobic (Oxidative Phosphorylation)

More information

How to detect early atherosclerosis ; focusing on techniques

How to detect early atherosclerosis ; focusing on techniques How to detect early atherosclerosis ; focusing on techniques Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon city, S. Korea Surrogates for Atherosclerosis Measures of endothelial

More information

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc

More information

New Insight about FFR and IVUS MLA

New Insight about FFR and IVUS MLA New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR

More information

Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art

Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art Harisios Boudoulas, MD, Dr, Dr. Hon. Professor, Honorary Professor, Academician Development of Coronary Artery

More information

SHOCKWAVE THERAPY FOR REFRACTORY ANGINA PECTORIS

SHOCKWAVE THERAPY FOR REFRACTORY ANGINA PECTORIS SHOCKWAVE THERAPY FOR REFRACTORY ANGINA PECTORIS S. Marra MD FESC G. Alunni MD Cardiology 2 Torino University S. Giovanni Battista Hospital Italy Ischemic area by SPECT O.C.83, Female Hypertension Previous

More information

Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm

Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Department of Cardiology Keiji Inoue Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita,

More information

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source

More information

NAM JUNE PAIK: Rhapsody in Video

NAM JUNE PAIK: Rhapsody in Video NAM JUNE PAIK: Rhapsody in Video 혈관연구회추계학회 2007.10.13 Renin-angiotensin-aldosterone System Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon University Gil Medical Center Incheon, Korea Cytokines oxldl Ang

More information

THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ

THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ Disclosures: On National Advisory Boards of: (1) Pfizer Pharmaceuticals (2) MSD (3) Roche Pharmaceuticals (4) Abbott International: AfME Rheumatology

More information

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand

CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand ENHANCED EXTERNAL COUNTER PULSATION Piyanuj Ruckpanich, MD. Cardiac Rehabilitation Center Perfect

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital

More information

Viability Testing Using Dynamic Echocardiography

Viability Testing Using Dynamic Echocardiography Viability Testing Using Dynamic Echocardiography Theodora A Zaglavara, MD, PhD Director of Echocardiography EUROMEDICA KYANOUS STAVROS HOSPITAL Thessaloniki GREECE Goals of Cardiac Imaging in Coronary

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Stem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford

Stem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford Stem Cells Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford Adult Stem Cells Unique cells that are capable of self-renewal Have the ability to differentiate

More information

Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy

Classification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

Erythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy

Erythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy Erythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy Melanie Hoch Cardiology & Angiology MHH, Hannover

More information

ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM

ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM Bernardo Nadal-Ginard, M.D., Ph.D. New York Medical College Angioplasty Summit 2004, Seoul 04/29/04 MYOCARDIAL

More information

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future Prof. Juhani Knuuti, MD, FESC Turku, Finland Disclosure: Juhani Knuuti, M.D. Juhani Knuuti, M.D. has financial

More information

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating

More information

For more information about how to cite these materials visit

For more information about how to cite these materials visit Author(s): Louis D Alecy, D.M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-commercial Share Alike 3.0 License:

More information

What the Cardiologist needs to know from Medical Images

What the Cardiologist needs to know from Medical Images What the Cardiologist needs to know from Medical Images Gerald Maurer Department of Cardiology Medical University of Vienna What kinds of Cardiologists Plumbers Electricians Photographers And then there

More information

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future

Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem

More information

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were

More information

TSP1 Secr Sec eted eted b m byy m n a y n y ce c ll cee s Upregulated by injury/stress W dely expressed CD47 S TSP1 only known ligand

TSP1 Secr Sec eted eted b m byy m n a y n y ce c ll cee s Upregulated by injury/stress W dely expressed CD47 S TSP1 only known ligand Parenchymal CD47 Promotes Renal IRI via Multiple Mechanisms Jeffrey S. Isenberg, MD, MPH Division of Pulmonary, Allergy and Critical Care Medicine Vascular Medicine Institute University of Pittsburgh School

More information

Perioperative Myocardial Infarction

Perioperative Myocardial Infarction Perioperative Myocardial Infarction Which patient should UNDERGO CORONARY ANGIOGRAPHY? The Cardiologists view Hans Rickli, St.Gallen 1 Experience Standards Risk stratification Team approach.. Tightrope

More information

Reactive oxygen species: Importance for ischemia/reperfusion (injury)

Reactive oxygen species: Importance for ischemia/reperfusion (injury) Physiologisches Institut Reactive oxygen species: Importance for ischemia/reperfusion (injury) Prof. Dr. Rainer Schulz Reactive oxygen species (ROS) in ischemia/reperfusion injury (IRI) ROS GOOD: Endogenous

More information

Impact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan

Impact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway Wei Yu,1,2 Wenliang Zha,1 Zhiqiang Ke,1 Qing Min,2 Cairong Li,1 Huirong Sun,3 and Chao

More information

AQUATIC ACTIVITY & THE BRAIN AQUATIC EXERCISE AND BLOOD VESSEL COMPLIANCE

AQUATIC ACTIVITY & THE BRAIN AQUATIC EXERCISE AND BLOOD VESSEL COMPLIANCE AQUATIC ACTIVITY & THE BRAIN Bruce E. Becker, MD, MS,FACSM Clinical Professor University of Washington beckerb@wsu.edu www.aquaticdoc.com Water Immersion to chest or higher Increased hydrostatic pressure

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement -- Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement -- JoonHyung Doh, MD, PhD Assistant Professor, Vision21 Cardiac and Vascular Center Inje University Ilsan Paik Hospital Goyang, Korea

More information

Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts

Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Serena Del Turco, Teresa Navarra, Giuseppina Basta, Raffaele De

More information